Position in EXEL
as of Jun 30, 2026
· filed Aug 24, 2026
Position Value
$544,100
+$115,200 QoQ
Shares Held
10,000
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#421
of 754 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026First Eagle Investment Management, LLC holds $23,452,930 across 2 Biotechnology names. EXEL ranks #2 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
3,671,287 | $22,908,830 | |
| 2 | EXEL |
Exelixis, Inc.
This page
|
10,000 | $544,100 |
All Filings in EXEL
Export CSV
12 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $544,100 | 10,000 | Shares | Sole | 2026-08-24 | |
| 2026-03-31 | $428,900 | 10,000 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $550,986 | 12,571 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $671,992 | 16,271 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $911,705 | 20,683 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $726,843 | 19,687 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $622,276 | 18,687 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $453,787 | 17,487 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $356,980 | 15,887 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $350,894 | 14,787 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $604,427 | 25,195 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $550,510 | 25,195 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||